| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27155ed29f9b0bfa281f4b21b26d709a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1024 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10 |
| filingDate |
2002-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d733692e775126e633924066f4a56cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36572c0c443e4d3d87fe64b1a10c86ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c5f3b353324fd4d45c91fc58b7ed91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073bedb7ed392d71eb36b989be347d6f |
| publicationDate |
2005-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005181998-A1 |
| titleOfInvention |
Prion inhibiting peptides and derivatives thereof |
| abstract |
Short peptides and derivatives or analogs thereof for the treatment or prevention of transmissible spongiform encephalopathies, in particular CJD are herein described. These peptides and/or their derivatives have been designed to block the conformational changes that occur in the prion protein (PrP) and which are implicated in the pathogenesis of transmissible spongiform encephalopathies as well as to dissolve the fibrillar deposits already formed |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9638702-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011081660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008213410-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8062895-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008171341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372593-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006057671-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006286672-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8673579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006275910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008095706-A1 |
| priorityDate |
2001-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |